Inovio Pharmaceuticals Inc (INO)
Healthcare
Biotechnology
0.70 $
+2.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Inovio Pharmaceuticals Inc (INO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -30 | -12 | -63 | -63 | -74 | -98 | -178 | -216 | -216 | -124 | -104 | -89 | |
| 1.6 | 1.9 | 3.1 | 3.5 | 5.0 | 5.5 | 4.6 | 4.7 | 5.5 | 3.5 | 3.1 | 3.0 | |
| 5.4 | 6.2 | 10 | 13 | 11 | 11 | 16 | 26 | 23 | 11 | 6.6 | 3.8 | |
| 6.2 | 5.6 | 9.5 | 16 | 10 | 17 | 96 | 27 | 30 | – | – | – | |
| 2.2 | 14 | -0.5 | 2.9 | 4.7 | -3.5 | -71 | 50 | 20 | -10 | -2.7 | -9.2 | |
| 1.4 | 2.8 | 3.9 | 10 | 2.1 | 1.0 | 1.5 | 1.2 | 1.0 | 0.3 | 0.5 | 0.3 | |
| -36 | -55 | 16 | -28 | 42 | -9.0 | -59 | -175 | 110 | 87 | 104 | 14 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 93 | 3.9 | – | – | – | – | – | |
| 59 | 85 | 4,300,000 | 94 | -0.6 | -0.9 | -4.0 | -4.6 | -1.4 | – | – | – | |
| – | – | 97 | 97 | 97 | 94 | 0.2 | 0.0 | 0.0 | 0.0 | -16 | 0.0 | |
| 72 | 84 | 7.8 | 96 | 31 | 105 | 465 | 211 | 82 | 5.0 | 51 | 53 | |
| 6.8 | 17 | -38 | 4.7 | -0.1 | -1.5 | 229 | -180 | -25 | -32 | 52 | -22 | |
| -31 | -15 | -66 | -74 | -76 | -99 | -179 | -217 | -217 | -125 | -105 | -89 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.